Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

PL EN


Preferences help
enabled [disable] Abstract
Number of results
2017 | 28 | 108 | 189-195

Article title

Lentinula edodes (Shiitake) – biological activity

Content

Title variants

Languages of publication

EN EO

Abstracts

EN
Lentinula edodes (Berk.) Pegler (shiitake) is a species with medicinal properties that is used primarily in traditional medicine, but also in conventional oncology treatment. The first records of Lentinula edodes cultivation reach back to China under the Song dynast (960-1127). The Japanese adopted the Chinese technique of shiitake cultivation, thus becoming its main producer. Currently, shiitake is used in the treatment of lifestyle diseases. Polysaccharides contained in this species strengthen the immune system, eliminate side effects of chemo and radiotherapy and have strong antitumor, antiviral and antibacterial properties. The year 1972 saw a discovery of substances with anti-atherosclerotic effects, with the most important being eritadenine (2 (R), 3 (R)-dihydroxy-4 – (9-adanyl) butyric acid) and statin – lovastatin. L. edodes is of interest to researchers due to its content of therapeutic compounds. These substances have antitumor, antifungal, antibacterial, anti-inflammatory, hypocholesterolemic, antihypertensive, hypoglycaemic and antioxidant effects.

Discipline

Year

Volume

28

Issue

108

Pages

189-195

Physical description

Contributors

  • Department of Pharmaceutical Botany, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland
author

References

  • 1. Akramiene D.; Kondrotas A.; Didziapetriene J.; Kevelaitis E. Medicina (Kaunas). 2007, 43, 597-606.
  • 2. Wasser, S. P. Encycl. Diet. Suppl. 2005, 653–664.
  • 3. Wasser S.P.; Weis A.L. Int. J. Med. Mushr. 1999, 1, 31-62.
  • 4. Casaril, K. B. P. B.; Kasuya, M. C. M.; Vanetti, M. C. D. Brazilian Arch. Biol. Technol. 2011, 54 (5), 991–1002.
  • 5. Chihara, G.; Maeda, Y.; Hamuro, J.; Sasaki, T.; Fukuoka, F. Nature 1969, 222 (5194), 687–688.
  • 6. Muta T. Curr. Pharm. Des. 2006, 12, 4155-4161.
  • 7. Bak, W. C.; Park, J. H.; Park, Y.; Ka, K. H. Mycobiology 2014, 42 (3), 301–304.
  • 8. Mizuno, T. Food Rev. Int. 1995, 11 (1), 109–128.
  • 9. Kamiya, T.; Saito, Y.; Hashimoto, M.; Seki, H. Tetrahedron Lett. 1969, 10 (53), 4729–4732.
  • 10. Morales, D.; Gil-Ramirez, A.; Smiderle, F. R.; Piris, A. J.; Ruiz-Rodriguez, A.; Soler-Rivas, C. Innov. Food Sci. Emerg. Technol. 2017, 41, 330-336.
  • 11. Drori, A.; Shabat, Y.; Ben Ya’acov, A.; Danay, O.; Levanon, D.; Zolotarov, L.; Ilan, Y. J. Med. Food 2016, 19 (4), 383–389.
  • 12. Mleczek, M.; Siwulski, M.; Rzymski, P.; Niedzielski, P.; Gąsecka, M.; Jasińska, A.; Budzyńska, S.; Budka, A. J. Environ. Sci. Heal. Part B 2017, 52 (3), 196–205.
  • 13. Kurashige, S.; Akuzawa, Y.; Endo, F. Immunopharmacol. Immunotoxicol. 1997, 19 (2), 175–183.
  • 14. Ogawa, T.; Ohwada, S.; Sato, Y.; Izumi, M.; Nakamura, S.; Takeyoshi, I.; Kawashima, Y.; Ohya, T.; Koyama, T.; Morishita, Y. Anticancer Res. 1998, 19 (1A), 375–379.
  • 15. Murata, T.; Hatayama, I.; Kakizaki, I.; Satoh, K.; Sato, K.; Tsuchida, S. Cancer Sci. 1996, 87 (11), 1171–1178.
  • 16. Kamiya, T.; Saito, Y.; Hashimoto, M.; Seki, H. J. Heterocycl. Chem. 1972, 9 (2), 359–362.
  • 17. Nakano, H.; Namatame, K.; Nemoto, H.; Motohashi, H.; Nishiyama, K.; Kumada, K. Hepatogastroenterology. 1999, 46 (28), 2662–2668.
  • 18. Yoshino, S.; Tabata, T.; Hazama, S.; Iizuka, N.; Yamamoto, K.; Hirayama, M.; Tangoku, A.; Oka, M. Anticancer Res. 1999, 20 (6C), 4707–4711.
  • 19. Takatsuki, F.; Namiki, R.; Kikuchi, T.; Suzuki, M.; Hamuro, J. Int. J. Immunopharmacol. 1995, 17 (6), 465471–469474.
  • 20. Fukushima, M.; Ohashi, T.; Fujiwara, Y.; Sonoyama, K.; Nakano, M. Exp. Biol. Med. 2001, 226 (8), 758–765.
  • 21. Hirasawa, M.; Shouji, N.; Neta, T.; Fukushima, K.; Takada, K. Int. J. Antimicrob. Agents 1999, 11 (2),151–157.
  • 22. Kawanobe, Y.; Sakamoto, M.; Nishioka, K. Nutr. Res. 1988, 8 (11), 1277–1286.
  • 23. Takeshita, K.; Hayashi, S.; Tani, M.; Kando, F.; Saito, N.; Endo, M. Surg. Oncol. 1996, 5 (1), 23–28.
  • 24. Masihi, K. N.; Madaj, K.; Hintelmann, H.; Gast, G.; Kaneko, Y. Int. J. Immunopharmacol. 1997, 19 (9–10), 463–468.
  • 25. Suzuki, M.; Iwashiro, M.; Takatsuki, F.; Kuribayashi, K.; Hamuro, J. Cancer Sci. 1994, 85 (4), 409–417.
  • 26. Liu, F.; Ooi, V. E. C.; Fung, M. C. Life Sci. 1999, 64 (12), 1005–1011.
  • 27. Jong, S. C.; Birmingham, J. M. Adv. Appl. Microbiol. 1993, 39, 153–184.
  • 28. Rincão, V. P.; Yamamoto, K. A.; Ricardo, N. M. P. S.; Soares, S. A.; Meirelles, L. D. P.; Nozawa, C.; Linhares, R. E. C. Virol. J. 2012, 9 (1), 37.
  • 29. Turlo, J.; Gutkowska, B.; Herold, F.; Dawidowski, M.; Słowiński, T.; Zobel, A. J. Toxicol. Environ. Heal. Part A 2010, 73 (17–18), 1211–1219.
  • 30. Hirasawa, M.; Shouji, N.; Neta, T.; Fukushima, K.; Takada, K. Int. J. Antimicrob. Agents 1999, 11 (2),151–157.

Document Type

article

Publication order reference

Identifiers

YADDA identifier

bwmeta1.element.psjd-c11f7058-e320-495a-985e-d14c8c7d85fa
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.